Prudential Financial
TARA icon

Prudential Financial’s Protara Therapeutics TARA Stock Holding History

Prudential Financial’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$194K Sell
50,730
-68,800
-58% -$327K ﹤0.01% 2241
2026
Q1 		$623K Buy
+119,530
New +$707K ﹤0.01% 1780

Other funds holding TARA

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.53B AUM 154.61% 1-Year Est. Return

Prudential Financial's TARA Position: Q2 2026 in Review

Prudential Financial reduced its Protara Therapeutics (TARA) stake by 58% in Q2 2026, selling an estimated $327K and leaving 50,730 shares worth $194K. The position accounts for ﹤0.01% of the portfolio, ranked #2241.

Prudential Financial first reported a position in TARA in Q1 2026 and has held it in 2 quarters since. The position peaked at $623K in Q1 2026. 120 funds tracked by Wall St. Rank hold TARA as of Q2 2026.

  • Prudential Financial held 50,730 shares of Protara Therapeutics worth $194K as of Q2 2026.
  • Prudential Financial sold 68,800 Protara Therapeutics shares in Q2 2026, an estimated $327K.
  • Protara Therapeutics made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #2241 holding.
  • Prudential Financial first reported a position in Protara Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • Prudential Financial's Protara Therapeutics position peaked at $623K in Q1 2026.
  • 120 funds tracked by Wall St. Rank held Protara Therapeutics as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.